124 related articles for article (PubMed ID: 11393289)
1. Inhibition of oxidative burst and chemotaxis in human phagocytes by Legionella pneumophila zinc metalloprotease.
Sahney NN; Summersgill JT; Ramirez JA; Miller RD
J Med Microbiol; 2001 Jun; 50(6):517-525. PubMed ID: 11393289
[TBL] [Abstract][Full Text] [Related]
2. Effect of Legionella pneumophila cytotoxic protease on human neutrophil and monocyte function.
Rechnitzer C; Kharazmi A
Microb Pathog; 1992 Feb; 12(2):115-25. PubMed ID: 1584005
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.
Blander SJ; Horwitz MA
J Exp Med; 1989 Mar; 169(3):691-705. PubMed ID: 2926324
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of polymorphonuclear leukocyte function by Legionella pneumophila exoproducts.
Sahney NN; Lambe BC; Summersgill JT; Miller RD
Microb Pathog; 1990 Aug; 9(2):117-25. PubMed ID: 2177516
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of the intracellular production of tissue-destructive protease by Legionella pneumophila multiplying within guinea-pig and human alveolar macrophages.
Rechnitzer C; Williams A; Wright JB; Dowsett AB; Milman N; Fitzgeorge RB
J Gen Microbiol; 1992 Aug; 138 Pt 8():1671-7. PubMed ID: 1527507
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human neutrophil and monocyte oxidative burst by Legionella pneumophila sonic extract.
Rechnitzer C; Kharazmi A; Nielsen H; Baek L
Eur J Clin Microbiol; 1987 Dec; 6(6):646-52. PubMed ID: 2831044
[TBL] [Abstract][Full Text] [Related]
7. An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease.
Blander SJ; Szeto L; Shuman HA; Horwitz MA
J Clin Invest; 1990 Sep; 86(3):817-24. PubMed ID: 2203824
[TBL] [Abstract][Full Text] [Related]
8. Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation.
Liel Y; Rudich A; Nagauker-Shriker O; Yermiyahu T; Levy R
Blood; 1994 May; 83(9):2646-53. PubMed ID: 8167344
[TBL] [Abstract][Full Text] [Related]
9. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.
Nash TW; Libby DM; Horwitz MA
J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140
[TBL] [Abstract][Full Text] [Related]
10. Icm/Dot-dependent inhibition of phagocyte migration by Legionella is antagonized by a translocated Ran GTPase activator.
Simon S; Wagner MA; Rothmeier E; Müller-Taubenberger A; Hilbi H
Cell Microbiol; 2014 Jul; 16(7):977-92. PubMed ID: 24397557
[TBL] [Abstract][Full Text] [Related]
11. Non-chemotactic influence of CXCL7 on human phagocytes. Modulation of antimicrobial activity against L. pneumophila.
González-Cortés C; Diez-Tascón C; Guerra-Laso JM; González-Cocaño MC; Rivero-Lezcano OM
Immunobiology; 2012 Apr; 217(4):394-401. PubMed ID: 22101183
[TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani lipophosphoglycan (LPG) inhibits respiratory burst and chemotaxis of dog phagocytes.
Panaro MA; Puccini V; Faliero SM; Marzio R; Marangi A; Lisi S; Brandonisio O
New Microbiol; 1996 Apr; 19(2):107-12. PubMed ID: 8722306
[TBL] [Abstract][Full Text] [Related]
13. Influence of nifedipine on plasma membrane fluidity and oxidative burst of polymorphonuclear leucocytes.
Grassi W; Serretti R; Core P; Muti S; Cervini C
Rheumatol Int; 1995; 14(6):221-5. PubMed ID: 7597376
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement.
Horwitz MA; Silverstein SC
J Exp Med; 1981 Feb; 153(2):386-97. PubMed ID: 7017062
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.
Horwitz MA; Silverstein SC
J Exp Med; 1981 Feb; 153(2):398-406. PubMed ID: 7241049
[TBL] [Abstract][Full Text] [Related]
16. Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea-pig pneumonia model.
Moffat JF; Edelstein PH; Regula DP; Cirillo JD; Tompkins LS
Mol Microbiol; 1994 Jun; 12(5):693-705. PubMed ID: 8052122
[TBL] [Abstract][Full Text] [Related]
17. Clofazimine-mediated enhancement of reactive oxidant production by human phagocytes as a possible therapeutic mechanism.
Anderson R; Zeis BM; Anderson IF
Dermatologica; 1988; 176(5):234-42. PubMed ID: 2838344
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila.
Blander SJ; Horwitz MA
J Clin Invest; 1991 Mar; 87(3):1054-9. PubMed ID: 1999485
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic effects on phagocyte chemiluminescence in vitro.
Pierce LA; Tarnow-Mordi WO; Cree IA
Int J Clin Lab Res; 1995; 25(2):93-8. PubMed ID: 7663012
[TBL] [Abstract][Full Text] [Related]
20. Genetics and molecular pathogenesis of Legionella pneumophila, an intracellular parasite of macrophages.
Cianciotto N; Eisenstein BI; Engleberg NC; Shuman H
Mol Biol Med; 1989 Oct; 6(5):409-24. PubMed ID: 2696860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
